Effect of fenofibrate on serum biochemical indicators and hepatic pathology in rats after bile duct ligation

Wang YiBo; Liu Yang; Sun YunTao

Issue 9

Sep. 2011

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2011 > 27(9): 951-954

PDF( 3694 KB)

Effect of fenofibrate on serum biochemical indicators and hepatic pathology in rats after bile duct ligation

Published Date: 2011-09-20

Abstract

Abstract

Objective To investigate the effect of Fenofibrate on serum hepatic biochemical indicators、MDA (malonaldehyde) and hepatic pathology in rats after bile duct ligation.Methods Rats were subjected to bile duct ligation to establish the cholestasis model.Twenty-four male Wistar rats were randomly divided into two groups equally: A = bile duct ligation+normal saline (BDL + NS) , B= BDL + fenofibrate (30 mg/kg daily) .All rats were sacrificed on 7th day after obtaining blood samples and liver tissue.Serum hepatic biochemical indicators were detected with automatic biochemistry analyzer;MDA assays were performed by spectrophotometer;Histopathological changes in liver was dyed with HE and observed under light microscope.Results There was no significant difference in terms of serum hepatic biochemical levels between group A and group B;The levels of MDA in rats of group B were significantly lower than in group A (P=0.001<0.05) ;The number of liver necrotic area in rats of group B was significantly smaller than in group A (P<0.05) , The number of biliary canals in rats of group B was significantly smaller than in group A (P<0.05) .Conclusion Fenofibrate administration attenuates the levels of MDA, reduces liver necrotic area and ductular proliferation.
- procetofen,
- jaundice,
- obstructive,
- disease models

FullText(HTML)

References(16)

References

[1]许海波, 巩鹏.PPARs在梗阻性黄疸肝脏损伤中的作用[J].国际外科学杂志, 2007, 34 (7) , 461-465.

[2]Cindoruk M, Kerem M, Karakan T, et al.Peroxisome prolif-erators-activated alphaagonist treatment ameliorates hepat-ic damage in rats with obstructive jaundice:an experimentalstudy[J].BMC Gastroenterology, 2007, 7 (44) :1-7.

[3]Lalloyer F, Staels B.Fibrates, glitazones, and peroxisomeproliferator-activated receptors[J].Arterioscler ThrombVasc Biol, 2010, 30 (5) :894-899.

[4]Post SM, Duez H, Gervois PP, et al.Fibrates suppress bileacid synthesis viaperoxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol27-hydroxylase expression[J].Arte-rioscler Thromb Vasc Biol, 2001, 21 (11) :1840-1845.

[5]Zollner G, Trauner M.Nuclear receptors as therapeutic tar-gets in cholestatic liver diseases[J].Br J Pharmacol, 2009, 156 (1) :7-27.

[6]Trauner M, Meierer PJ, Boyer JL.Molecular pathogenesisof cholestasis[J].New Eng J Med, 1998, 339 (17) :1217-1227.

[7]Aller MA, Arias JL, Prieto I, et al.Bile duct ligation:step-by-step to cholangiocyte inflammatory tumorigenesis[J].Eur J Gastroenterol Hepatol, 2010, 22 (6) :651-661.

[8]Reddy JK, Hashimoto T.Peroxisomal beta-oxidation andperoxisome proliferator-activated receptor alpha:an adap-tive metabolic system[J].Annu Rev Nutr, 2001, 21:193-230.

[9]Qi C, Zhu Y, Reddy JK.Peroxisome proliferator-activatedreceptors, coactivators, and downstream targets[J].CellBio-chem Biophys, 2000, 32:187-204.

[10]Bulhak AA, Jung C, Ostenson CG, et al.PPAR-alpha acti-vation protects the type 2 diabetic myocardium against ische-mia-reperfusion injury:involvement of the PI3-Kinase/Aktand NO pathway[J].Am J Physiol Heart Circ Physiol, 2009, 296 (3) :H719-H727.

[11]Collino M, Aragno M, Mastrocola R, et al.Oxidative stressand inflammatory response evoked by transient cerebral is-chemia reperfusion:effects of the PPAR-alpha agonistWY14643[J].Free Radic Biol Med, 2006, 41 (4) :579-589.

[12]曲艳萍, 张文锐.浅谈非诺贝特的副作用[J].中外医疗, 2010, 2 (29) :176-176.

[13]Kobayashi A, Suzuki Y, Kuno H, et al.Effects of fenofibrateon plasma and hepatic transaminase activities and hepatictransaminase gene expression in rats[J].J Toxicol Sci, 2009, 34 (4) :377-387.

[14]Tomkiewicz C, Muzeau F, Edgar AD, et al.Opposite regula-tion of the rat and human cytosolic aspartate aminotrans-ferase genes by fibrates[J].Biochem Pharmacol, 2004, 67 (2) :213-225.

[15]尹蓉, 王沁, 富翠芹.姜黄素对酒精诱导的大鼠脂质过氧化反应的影响[J].世界华人消化杂志, 2008, 16 (13) :1383-1387.

[16]Tolman KG.Defining patient risks from expanded preventivetherapies[J].Am J Cardiol, 2000, 85 (12A) :15E-19E.

Relative Articles

[1]	WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018
[2]	Peng Lu:Cheng, Shao ZhangFeng, Chen JiaQin, Chen Wei. Effect of aerobic exercise combined with silybin on intestinal mucosal barrier in mice with obstructive jaundice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1577-1583. doi: 10.3969/j.issn.1001-5256.2020.07.025
[3]	Chen WeiWei, Huang Kun, Liu Rui, Liu ChengLi. Clinical effect of percutaneous transhepatic cholangial drainage combined with biliary stent implantation in treatment of high malignant obstructive jaundice and the influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2019, 35(3): 559-564. doi: 10.3969/j.issn.1001-5256.2019.03.021
[4]	Zhang JiYu, Fan XingLiang. Research advances in the mouse model of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2235-2238. doi: 10.3969/j.issn.1001-5256.2017.11.041
[5]	Li Jing, Wu GuangLi, Wang Wei, Xiao Xin, Liu HuiNa, Qu DongDong, Cai YiWei. Analysis of pathogenic bacteria in bile and blood of patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2017, 33(2): 320-323. doi: 10.3969/j.issn.1001-5256.2017.02.025
[6]	Luo WeiWei, Yu ShuiPing. Research advances in animal models of obstructive jaundice[J]. Journal of Clinical Hepatology, 2017, 33(9): 1820-1823. doi: 10.3969/j.issn.1001-5256.2017.09.043
[7]	Li Dong, Lu ZhongHua, Gan JianHe. Establishment of a rat model of early-stage liver failure and Th17/Treg imbalance[J]. Journal of Clinical Hepatology, 2016, 32(5): 928-932. doi: 10.3969/j.issn.1001-5256.2016.05.025
[8]	Li ZhangZheng, Liu QuanDa, Yu HuiJie, Hu WenWei, Li Xue, Liu MingHao. Correlation between serum levels of complement C5a and liver fibrosis markers in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(3): 495-498. doi: 10.3969/j.issn.1001-5256.2016.03.020
[9]	Pan YaJun, Sun ShaoFu. Predictive value of serum CA19-9 in predicting acute cholangitis in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(8): 1553-1556. doi: 10.3969/j.issn.1001-5256.2016.08.024
[10]	Wen Nuan, Zhu YiXiang, Lu: RenGeng, Kang JiangHui, Han HongJun, Xu HanBin. Expression and significance of UCP-2 in rats with obstructive jaundice and bile flow restoration[J]. Journal of Clinical Hepatology, 2015, 31(1): 88-92. doi: 10.3969/j.issn.1001-5256.2015.01.019
[11]	Yu Yuan, Yang ZongGuo, Chen ChiChi, Lu YunFei, Xu QingNian, Chen XiaoRong. Efficacy of adjuvant therapy with fenofibrate for primary biliary cirrhosis: a Meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1630-1633. doi: 10.3969/j.issn.1001-5256.2015.10.017
[12]	Zhang YuHuai, Luo ZhangJiang, Wang WenHu. Dynamic changes in plasma CD62Pand their significance among patients with obstructive jaundice and cholecystolithiasis[J]. Journal of Clinical Hepatology, 2014, 30(11): 1157-1159. doi: 10.3969/j.issn.1001-5256.2014.11.016
[13]	Yang ShengHua, Zhang ChengHua, Du LingHong. Relationship between ways of nutritional support and immune function in patients with malignant obstructive jaundice after PTCD[J]. Journal of Clinical Hepatology, 2014, 30(11): 1148-1152. doi: 10.3969/j.issn.1001-5256.2014.11.014
[14]	Huang HaiYan, Xin YongNing, Jiang Man, Jin WenWen, Jiang XiangJun, Xuan ShiYing. Research advances in animal models of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2014, 30(9): 948-953. doi: 10.3969/j.issn.1001-5256.2014.09.028
[15]	Wang TianRan, Wang LanTian, Qu YuanQing, Gu Yu, Zou ZiYing, Chen Li. Comparative analysis of serum markers of cardiac function in a rabbit model of and human patients with obstructive jaundice [J]. Journal of Clinical Hepatology, 2013, 29(3): 227-229.
[16]	Li ZhangZheng, Hu WenWei, Li Wen, Li QingShan, Liu QuanDa, Cheng LiuFang, Zhou NingXin. Effect of time of biliary drainage on biliary obstructive liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2011, 27(9): 944-946.
[17]	Sun LinLin, Shi Jun, Hao JingHua, Ren WanHua, Yan ChunYing, Zhang Jie, Lin XiaoYan, Cui Bin. Effect of high-fat diet on establishment of a rat non-alcoholic steatohepatitis/liver fibrosis model[J]. Journal of Clinical Hepatology, 2011, 27(3): 254-257+272.
[18]	Zhang ZhenZhong, Chen WuXia, Sun YuanYuan. The clinical analysis on endoscope technique applicated for patients suffering from extrahepatic cholestatic jaundice[J]. Journal of Clinical Hepatology, 2011, 27(9): 918-921.
[19]	Lou GuoHua, Liu YanNing, Yin ChunBen, Chen Feng, Jia ZhanSheng, Chen Zhi. Preliminary study of HCV mouse model induced by infectious HCV 2a plasmid[J]. Journal of Clinical Hepatology, 2011, 27(1): 72-75.
[20]	Sun YunTao, Ban Bo, Wang YiBo, Liu Yang. Effect of fenofibrate on hepatocyte apoptosis and hepatic glycogen in rats with obstructive jaundice[J]. Journal of Clinical Hepatology, 2011, 27(9): 947-950.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2427) PDF downloads(621)

Effect of fenofibrate on serum biochemical indicators and hepatic pathology in rats after bile duct ligation

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Effect of fenofibrate on serum biochemical indicators and hepatic pathology in rats after bile duct ligation

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content